![Toru Seo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Toru Seo is the founder of HISHOH Biopharma Co., Ltd. (founded in 2021) and held the title of Advisor.
Dr. Seo is currently working as a Director at Cellusion Inc. Dr. Seo obtained a doctorate degree from Wake Forest University.
| Unternehmen | Position | Beginn |
|---|---|---|
Cellusion Inc.
 Cellusion Inc. Miscellaneous Commercial ServicesCommercial Services Engages in regenerating corneal endothelium using IPS cells for treatment of bullous keratopathy | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
HISHOH Biopharma Co., Ltd.
 HISHOH Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in development of allergen immunotherapy | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 3 |
|---|---|
Wake Forest University
 Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellusion Inc.
Cellusion Inc. Miscellaneous Commercial ServicesCommercial Services Engages in regenerating corneal endothelium using IPS cells for treatment of bullous keratopathy | Commercial Services |
HISHOH Biopharma Co., Ltd.
HISHOH Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in development of allergen immunotherapy | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
